Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Invested Capital (2019 - 2025)

Historic Invested Capital for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $1.0 billion.

  • Legend Biotech's Invested Capital fell 939.4% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 939.4%. This contributed to the annual value of $1.3 billion for FY2024, which is 1404.22% down from last year.
  • Legend Biotech's Invested Capital amounted to $1.0 billion in Q3 2025, which was down 939.4% from $1.0 billion recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Invested Capital ranged from a high of $1.5 billion in Q4 2023 and a low of $206451.0 during Q1 2021
  • In the last 5 years, Legend Biotech's Invested Capital had a median value of $1.0 billion in 2025 and averaged $929.8 million.
  • As far as peak fluctuations go, Legend Biotech's Invested Capital soared by 35890044.08% in 2022, and later crashed by 1762.78% in 2024.
  • Over the past 5 years, Legend Biotech's Invested Capital (Quarter) stood at $1.0 billion in 2021, then grew by 14.23% to $1.1 billion in 2022, then soared by 31.32% to $1.5 billion in 2023, then fell by 14.04% to $1.3 billion in 2024, then decreased by 21.64% to $1.0 billion in 2025.
  • Its Invested Capital stands at $1.0 billion for Q3 2025, versus $1.0 billion for Q2 2025 and $1.0 billion for Q1 2025.